Prevalence of anemia and hematological findings in covid-19 patients in Saudi Arabia
By: Almehmadi, Mazen
.
Contributor(s): Salih, Magdi.
Publisher: Bangalore Association of Pharmaceutical Teachers of India (APTI) 2022Edition: Vol.56(4), Oct-Dec.Description: 1226-1231p.Subject(s): PHARMACEUTICSOnline resources: Click here
In:
Indian journal of pharmaceutical education and researchSummary: Objectives: The aim of this study was to estimate the prevalence of anemia among
COVID-19 patients in Saudi Arabia and evaluate their hematological parameters. Materials
and Methods: A descriptive, cross-sectional, hospital-based study was conducted
between February 2021 to March 2021, data collection covered the period between
September 2020 to March 2021. All the patients were hospitalized for confirmed
COVID-19. Results: A total of 6048 COVID-19 patients included in our study, 2358
(48.9%) were anemic, 3666 (60.61%) were normal HGB level, and only 24 (0.49%)
were having polycythemia. Hemoglobin level ranged from 5 g/dL to 18 g/dL with a median
(interquartile range) of 11.8 g/dL (8.9 to 13.1) g/dL. The median for male (interquartile
range) was for anemic patient’s 9.8 g/dL (8.5 to 11.4) g/dL, normal 14 g/dL (13.5 to
14.8) g/dL, and polycythemia 17.4 g/dL (17.2 to 17.7) g/dL. The median for female
(interquartile range) was for anemic patient’s 9.1 g/dL (8.2 to 10.2) g/dL, normal 13.5 g/
dL (12.5 to 14.5) g/dL, and polycythemia 17 g/dL (16.82 to 17.2) g/dL. Hematological
parameters detected are indicative of severe complications in anemic patients compared
to non-anemic patients. Conclusion: Our findings were consistent with other studies that
reported poor outcomes of anemia in COVID-19 patients.
| Item type | Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|
Articles Abstract Database
|
School of Pharmacy Archieval Section | Not for loan | 2023-0130 |
Objectives: The aim of this study was to estimate the prevalence of anemia among
COVID-19 patients in Saudi Arabia and evaluate their hematological parameters. Materials
and Methods: A descriptive, cross-sectional, hospital-based study was conducted
between February 2021 to March 2021, data collection covered the period between
September 2020 to March 2021. All the patients were hospitalized for confirmed
COVID-19. Results: A total of 6048 COVID-19 patients included in our study, 2358
(48.9%) were anemic, 3666 (60.61%) were normal HGB level, and only 24 (0.49%)
were having polycythemia. Hemoglobin level ranged from 5 g/dL to 18 g/dL with a median
(interquartile range) of 11.8 g/dL (8.9 to 13.1) g/dL. The median for male (interquartile
range) was for anemic patient’s 9.8 g/dL (8.5 to 11.4) g/dL, normal 14 g/dL (13.5 to
14.8) g/dL, and polycythemia 17.4 g/dL (17.2 to 17.7) g/dL. The median for female
(interquartile range) was for anemic patient’s 9.1 g/dL (8.2 to 10.2) g/dL, normal 13.5 g/
dL (12.5 to 14.5) g/dL, and polycythemia 17 g/dL (16.82 to 17.2) g/dL. Hematological
parameters detected are indicative of severe complications in anemic patients compared
to non-anemic patients. Conclusion: Our findings were consistent with other studies that
reported poor outcomes of anemia in COVID-19 patients.
Click on an image to view it in the image viewer
There are no comments for this item.